PRLD – prelude therapeutics incorporated (US:NASDAQ)
Stock Stats
News
Prelude Therapeutics Incorporated (NASDAQ: PRLD) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating. They now have a $3.00 price target on the stock.
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences [Yahoo! Finance]
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Form 4 Prelude Therapeutics For: Jun 14 Filed by: 667, L.P.
Form 4 Prelude Therapeutics For: Jun 14 Filed by: Sandor Victor
Form 4 Prelude Therapeutics For: Jun 14 Filed by: FRIEDMAN PAUL A
Form 4 Prelude Therapeutics For: Jun 14 Filed by: Bonita David P
Form 4 Prelude Therapeutics For: Jun 14 Filed by: Dier Mardi
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.